I-Sitagliptin Phosphate Monohydrate CAS 654671-77-9 Purity >99.0% (HPLC) API Factory High Quality
Ubonelelo ngeSitagliptin Phosphate Monohydrate Eziyeleleneyo neziPhakathi:
I-Sitagliptin API CAS 486460-32-6
I-Sitagliptin Phosphate Monohydrate API CAS 654671-77-9
2,4,5-Trifluorophenylacetic Acid CAS 209995-38-0
Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid CAS 486460-00-8
I-Sitagliptin Triazole Hydrochloride CAS 762240-92-6
I-Sitagliptin Phosphate Monohydrate ePhakathi CAS 486460-21-3
Igama leMchiza | ISitagliptin Phosphate Monohydrate |
Izithethantonye | (R) -3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4- (2,4,5-trifluorophenyl)butan-1-one phosphate monohydrate |
Inombolo yeCAS | 654671-77-9 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C16H20F6N5O6P |
Ubunzima beMolekyuli | 523.3240802 |
Indawo yokunyibilika | 202.0~204.0℃ |
Ukunyibilika kwamanzi | Inyibilika emanzini |
Ukujikeleziswa okuthe ngqo | -18.0°~-23.0° (C=1, Amanzi) |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kuMhlophe oMhlophe wePowder |
Ukuchongwa yi-HPLC | Ixesha lokugcinwa kwesampulu lihambelana nomgangatho wereferensi |
I-IR-Infrared Spectrum | I-IR Absorption Spectrum yesampulu iya kuhambelana naleyo ye-spectrum eqhelekileyo |
Iphosphate | Iyahambelana |
Ubunyulu / Indlela yokuHlalutya | > 99.0% (HPLC kwisiseko esomisiweyo) |
Isiqulatho samanzi (KF) | 3.3%~4.4% |
Intsalela kwi-Ignition | ≤0.20% |
Isulphate | ≤0.02% |
I-Chloride | ≤0.05% |
Ukungacoceki kweChiral | <0.50% |
Izinto ezinxulumeneyo | |
Ukungacoceki Okukodwa | <0.50% |
Ukungcola ngokupheleleyo | <1.0% |
I-Ethyl Acetate | <0.50% |
Iintsimbi ezinzima | <20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | AbaPhakathi bamayeza |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.
I-Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9), ichiza elitsha lokunyanga uhlobo lwe-2 yeswekile.Ngo-Agasti ka-2009, ichiza lamkelwa yiManyano yaseYurophu njengechiza lokuqala kunyango lwe-2 seswekile.I-Sitagliptin Phosphate yeyokuqala i-FDA-evunyiweyo yi-dipeptidyl peptidase-IV inhibitor ukuba isetyenziswe kunyango lwe-2 yeswekile ukuza kuthi ga ngoku, phantsi kwegama lezorhwebo elithi Januvia.I-Dipeptidylpeptidase Ⅳ (DPP-Ⅳ) ithoba ngokukhawuleza nangokufanelekileyo i-GLP-1, i-GLP-1, esesona sikhuthazi sisebenzayo sokuvelisa i-insulin kunye nokukhuselwa Ke ngoko, ukuvinjwa kwe-DPP-IV kunokonyusa indima ye-GLP-1 engapheliyo, ngaloo ndlela inyusa igazi. amanqanaba e-insulin, ngaloo ndlela kunciphisa kunye nokugcina amanqanaba eglucose yegazi kwizigulane ezinesifo seswekile.Okwangoku, iyeza liqinisekisile ukuba i-DPP-IV inhibitor luhlobo olutsha lweziyobisi ezichasayo, kwaye iziphumo zeklinikhi zibonisa ukuba iziyobisi zinefuthe elihle le-hypoglycemic.Ngenxa yokuba i-GLP-1 idlala indima exhomekeke kwi-glucose ekukhuthazeni ukuveliswa kwe-insulin kunye nokukhupha, ukusabela okungathandekiyo okuqhelekileyo okufana ne-hypoglycemia kunye nokuzuza ubunzima okubangelwa ukusetyenziswa kweziyobisi ze-antidiabetic akwenzeki.